<DOC>
	<DOCNO>NCT00183846</DOCNO>
	<brief_summary>This study people advance cancer digestive tract cancer completely remove surgery . Radiation therapy commonly use treatment type cancer combination chemotherapy drug , call 5-fluorouracil ( 5-FU ) . In study , doctor administer standard dose radiation therapy combination investigational chemotherapy drug , call irinotecan . Irinotecan decrease size tumor also appear increase effectiveness radiation . The purpose study determine high dose irinotecan give safely combination radiation therapy , determine side effect two treatment give together . Irinotecan approve Food Drug Administration ( FDA ) treatment colon cancer , approve cancer digestive tract . However , FDA allow use research study .</brief_summary>
	<brief_title>Study Irinotecan Administered Continuous Infusion Radiation Therapy Upper Gastrointestinal Cancers</brief_title>
	<detailed_description />
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Gastrointestinal Neoplasms</mesh_term>
	<mesh_term>Bile Duct Neoplasms</mesh_term>
	<mesh_term>Duodenal Neoplasms</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<mesh_term>Camptothecin</mesh_term>
	<criteria>Histologically confirm neoplasm upper gastrointestinal tract ( pancreas , stomach , duodenum , common bile duct , ampulla Vater ) metastatic tumor upper abdomen . Eligible patient include patient locally advance unresectable tumor , positive surgical margin , local recurrence resect stage IIIII pancreatic , gastric , duodenum , bile duct ampulla Vater carcinoma . Performance status SWOG 02 Fully recover prior surgery chemotherapy ( great equal 4 week ) . Patients previously treat 5FU gemcitabine may start therapy 2 week last dose 5FU gemcitabine . Absolute granulocyte count ( AGC ) &gt; 1500 ; platelet &gt; 100,000 ; serum creatinine &lt; 2.0 mg/dl ; total bilirubin &lt; 2.0 mg/dl ; AST ALT alkaline phosphatase &lt; 3 time upper limit normal . Prior chemotherapy allow . Prior radiation therapy upper abdomen Tumors gastroesophageal junction . Other medical , psychological social circumstance , opinion investigator , would prevent participation clinical trial Pregnancy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>pancreas</keyword>
	<keyword>stomach</keyword>
	<keyword>common bile duct cancer</keyword>
	<keyword>ampulla Vater cancer</keyword>
</DOC>